What the business is, and whether it's a good one at a fair price.
Operates multi-specialty hospitals under the Medanta brand, providing inpatient and outpatient clinical care across facilities in India. As of March 31, 2026, the network runs 6 hospitals with 3,665 installed beds, with 5 additional hospitals in the pipeline. Revenue is generated from patient services — hospitalisation, surgeries, consultations and diagnostics — and is split between mature hospitals (such as the Gurugram flagship) and developing units (Lucknow, Patna, Noida). In Q1 FY26, mature hospitals delivered total income of ₹7,006 mn at 23.4% EBITDA margin, while developing hospitals (Lucknow, Patna) delivered ₹3,219 mn at 29.3% margin with 64% occupancy. International patient revenue from CIS, Africa and Southeast Asia rebounded 34% YoY in Q1 FY26. The group has a 2,000-bed expansion pipeline over 3-4 years, including a 550-bed Noida hospital (opened November 2025), a 110-bed Ranchi unit (July 2025) and a Guwahati hospital scaled up to 650 beds, with FY27 capex guided at ₹800-900 crore. Employee expenses (24.9% of revenue) and materials consumed (20.0% of revenue) are the largest cost lines.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from GLOBAL HEALTH LIMITED's filed financials and exchange disclosures
GLOBAL HEALTH LIMITED is a Healthcare Services company listed on NSE and BSE, trading under the symbol MEDANTA.
Yes. Over the trailing twelve months GLOBAL HEALTH LIMITED reported a net profit of ₹552 Cr on revenue of ₹4,683 Cr.
Yes. The dividend yield is 0.03% at the current price. It paid out 2% of its profit as dividend in FY26.
No. Debt stands at 0.30× equity, and it carries net debt of ₹1,063 Cr. That is lower than 35% of its 24 Hospital peers.
On trailing P/E, GLOBAL HEALTH LIMITED ranks 25 of 30 in Hospital — cheaper than 17% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session GLOBAL HEALTH LIMITED moves 1.18% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by GLOBAL HEALTH LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.